The Asian Fund for Cancer Research (AFCR) has launched a new program which is placing innovative cancer research breakthroughs onto a path of commercialization. The new initiative provides chosen projects a combination of honorarium, capital, exposure-generating opportunities and enhanced access to AFCR’s network of cancer industry professionals and researchers in the region and around the world. It’s goal: to catalyze and advance promising laboratory cancer research discoveries that are either still within universities or medical centers or that have recently spun-out of such institutions.
The program, the Bridging Research from Academia to Cancer Entrepreneurship (BRACE) Award, consists of two stages:
- BRACE Award Pitches. Half-day or whole-day sets of presentations are being conducted by AFCR, coordinated with major universities, cancer centers, hospitals, technology commercialization offices or science parks in Asia, made by scientists—lead project investigators within labs or chief science or technology officers within start-up companies—and with emphasis on a project’s feasibility, novelty and patient impact, as well as consideration to any unique low-cost access features for Asian patients. At each, one winner and one runner-up is selected—and awarded an honorarium of HK$25,000 and HK$10,000 respectively.
- BRACE Venture Competition. The pool of winners and runners-up will move forward to present their updated projects at a full day of presentations where the most investable projects receive up to HK$2,000,000 in funding from AFCR. Candidates will be judged by some of the most respected minds in the cancer research, investment and technology commercialization fields.
Learn more about the BRACE Award here.
Next BRACE Award Pitches
Prior Brace Award Pitches
Date Month Year
Sign up for e-mails to learn about future BRACE Award Pitches and other developments.